The purpose of this study is to assess the efficacy, feasibility, and acceptability of Virtual Reiki therapy as a complementary treatment for patients with systemic lupus erythematosus (SLE). The study also aims to investigate the feasibility, acceptability, and adherence of integrating Virtual Reiki therapy within the healthcare system for patients with SLE. Participants receiving standard of care (SOC) treatment for SLE will continue SOC while receiving research-specific Virtual Reiki therapy once per week for 8 weeks. Each study session will be delivered remotely by a Certified Reiki Practitioner Level II or higher.

Inclusion Criteria:

1. Adult aged 18 and older at the time of informed consent
2. Diagnosed with SLE (based on 2019 American College of Rheumatology (ACR)/ European League Against Rheumatism (EULAR) criteria)
3. Currently receiving SOC treatment for SLE at NYU Langone Orthopedic Center
4. Able and willing to provide consent and participate in 8 weekly virtual Reiki sessions
5. Has access to reliable internet, have an active email address, and able to utilize WebEx
6. Able to read, speak and understand English

Exclusion Criteria:

1. Under 18 years of age
2. Patients experiencing severe disease activity requiring hospitalization at time of screening
3. Unable to read, speak and understand English
4. No access to internet
5. Not willing to participate in weekly virtual Reiki sessions
6. Currently enrolled in another interventional clinical trial

The de-identified participant data from the final research dataset will be shared upon reasonable request beginning 9 to 36 months after publication or as required by a condition of awards or supporting agreements, provided the requesting investigator executes a data use agreement with NYU Langone Health. This instance of data sharing will also require separate IRB review as well as review from NYU Langone's Data Sharing Strategy Board (DSSB). Requests should be directed to: Monica.Gamez-Perez@NYULangone.org. The protocol and statistical analysis plan will be posted on Clinicaltrials.gov only as required by federal regulation or supporting awards and agreements.

Beginning 9 months and ending 36 months following article publication or as required by a condition of awards and agreements supporting the research.

The investigator who proposed to use the data will be granted access upon reasonable request. Requests should be directed to Monica.Gamez-Perez@NYULangone.org. To gain access, data requestors will need to sign a data access agreement. This instance of data sharing will also require separate IRB review as well as review from NYU Langone's DSSB.